As a result, the optimal risk model composed of six genes (CSNK1D, CSNK1E, ACHE, SIRT1, TRAF6, and NFKB1) was screened out and named RCC-MP6 (Figure 10(c)). This evidence concerns the gene ACHE and renal cell carcinoma.